191 related articles for article (PubMed ID: 23603256)
1. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.
Wang F; Li T; Zhang B; Li H; Wu Q; Yang L; Nie Y; Wu K; Shi Y; Fan D
Biochem Biophys Res Commun; 2013 May; 434(3):688-94. PubMed ID: 23603256
[TBL] [Abstract][Full Text] [Related]
2. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
[TBL] [Abstract][Full Text] [Related]
3. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells.
Hao Z; Li X; Qiao T; Du R; Hong L; Fan D
Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721
[TBL] [Abstract][Full Text] [Related]
4. Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression.
Zhu H; Xia L; Zhang Y; Wang H; Xu W; Hu H; Wang J; Xin J; Gang Y; Sha S; Xu B; Fan D; Nie Y; Wu K
PLoS One; 2012; 7(2):e31431. PubMed ID: 22363646
[TBL] [Abstract][Full Text] [Related]
5. miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.
Zhu F; Wu Q; Ni Z; Lei C; Li T; Shi Y
Int J Mol Med; 2018 Jul; 42(1):228-236. PubMed ID: 29568890
[TBL] [Abstract][Full Text] [Related]
6. MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog/smoothened.
Zhang XL; Shi HJ; Wang JP; Tang HS; Cui SZ
Int J Clin Exp Pathol; 2015; 8(6):6397-406. PubMed ID: 26261515
[TBL] [Abstract][Full Text] [Related]
7. ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting
Tan B; Li Y; Zhao Q; Fan L; Wang D
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126848
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
Zhu CY; Lv YP; Yan DF; Gao FL
Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-19a regulates the proliferation, migration and invasion of human gastric cancer cells by targeting CUL5.
Zhu Y; Li L; Hou D; Ouyang Y; Guo X; Wang Y; Li J; Gong K
Arch Biochem Biophys; 2019 Feb; 662():93-100. PubMed ID: 30521783
[TBL] [Abstract][Full Text] [Related]
10. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
[TBL] [Abstract][Full Text] [Related]
11. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.
Shang Y; Zhang Z; Liu Z; Feng B; Ren G; Li K; Zhou L; Sun Y; Li M; Zhou J; An Y; Wu K; Nie Y; Fan D
Oncogene; 2014 Jun; 33(25):3267-76. PubMed ID: 23893241
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein.
Shi Y; Zhang Y; Zhao Y; Hong L; Liu N; Jin X; Pan Y; Fan D
Cancer Biol Ther; 2004 Apr; 3(4):377-81. PubMed ID: 14726695
[TBL] [Abstract][Full Text] [Related]
13. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer.
Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L
Int J Biol Macromol; 2019 May; 128():574-582. PubMed ID: 30710584
[TBL] [Abstract][Full Text] [Related]
14. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.
Zhu H; Wu H; Liu X; Evans BR; Medina DJ; Liu CG; Yang JM
Biochem Pharmacol; 2008 Sep; 76(5):582-8. PubMed ID: 18619946
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
Zhang X; Chen Y; Zhao P; Zang L; Zhang Z; Wang X
Leuk Lymphoma; 2017 Apr; 58(4):932-940. PubMed ID: 27830963
[TBL] [Abstract][Full Text] [Related]
16. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
17. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
18. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
[TBL] [Abstract][Full Text] [Related]
19. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
[TBL] [Abstract][Full Text] [Related]
20. miR-138 might reverse multidrug resistance of leukemia cells.
Zhao X; Yang L; Hu J; Ruan J
Leuk Res; 2010 Aug; 34(8):1078-82. PubMed ID: 19896708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
